| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Canada | 4 | |
| #3 | United States | 4 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Australia | 2 | |
| #6 | Brazil | 2 | |
| #7 | China | 2 | |
| #8 | Israel | 2 | |
| #9 | Republic of Korea | 2 | |
| #10 | Mexico | 1 | |
| #11 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Svenstrup Niels | 14 |
| #2 | Mcarthur James | 9 |
| #3 | Kong Jianshe | 7 |
| #4 | Zhang Jun | 7 |
| #5 | Qin Liang | 7 |
| #6 | Meng Xiao | 7 |
| #7 | Zhu Jingyang | 7 |
| #8 | Pitak Mateusz | 6 |
| #9 | Wei Haojuan | 6 |
| #10 | Patterson Adam Ross | 6 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020227399A1 | Pde9 inhibitors for treating thalassemia | |
| WO2020206336A1 | Pde9 inhibitors for treating sickle cell disease | |
| AU2019328299A1 | PDE9 inhibitors for treating sickle cell disease | |
| CA3100988A1 | Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7h-imidazo[1,5-a]pyrazin-8-one | |
| CN111183140A | Methods of making and using PDE9 inhibitors |